Search

The recent increase in the number of people with diabetes and the high incidence of complications carry a significant socioeconomic burden in addition to the disease burden and impact on personal health. Therefore, the Korean Diabetes Association and the Korean government have been making efforts to prevent the progression from pre-diabetes to diabetes through screening tests and to reduce diabetes complications and associated mortality in diabetic patients. Several studies in Korea have shown that glycated hemoglobin (HbA1c) provides complementary information to fasting plasma glucose (FPG) and improves clinical utility for diabetes screening. We hope that this consensus meeting will serve as an opportunity to identify additional diabetic patients who have not been diagnosed through a combination of FPG and HbA1c during a medical check-up. Our study is aimed to significantly reduce the lead time between diabetes onset and clinical diagnosis and initiation of diabetes treatment. [ABSTRACT FROM AUTHOR]

The accuracy and convenience of continuous glucose monitoring (CGM), which efficiently evaluates glycemic variability and hypoglycemia, are improving. There are two types of CGM: professional CGM and personal CGM. Personal CGM is subdivided into real-time CGM (rt-CGM) and intermittently scanned CGM (isCGM). CGM is being emphasized in both domestic and foreign diabetes management guidelines. Regardless of age or type of diabetes, CGM is useful for diabetic patients undergoing multiple insulin injection therapy or using an insulin pump. rt-CGM is recommended for all adults with type 1 diabetes (T1D), and can also be used in type 2 diabetes (T2D) treatments using multiple insulin injections. In some cases, short-term or intermittent use of CGM may be helpful for patients with T2D who use insulin therapy other than multiple insulin injections and/or oral hypoglycemic agents. CGM can help to achieve A1C targets in diabetes patients during pregnancy. CGM is a safe and cost-effective alternative to self-monitoring blood glucose in T1D and some T2D patients. CGM used in diabetes management works optimally with proper education, training, and follow up. To achieve the activation of CGM and its associated benefits, it is necessary to secure sufficient repetitive training and time for data analysis, management, and education. Various supports such as compensation, insurance coverage expansion, and reimbursement are required to increase the effectiveness of CGM while considering the scale of benefit recipients, policy priorities, and financial requirements. [ABSTRACT FROM AUTHOR]